Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study

Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study

Background: This study aimed to investigate whether the addition of candesartan to the standard care regimen improved the outcome in patients with coronavirus 2019 (COVID-19). Methods: A prospective non-randomized open-label study was undertaken from May to August 2020 on 75 subjects (aged 18–70 yea...

Full description

Bibliographic Details
Main Authors: Antonia Anna Lukito, Allen Widysanto, Theo Audi Yanto Lemuel, Ignatius Bima Prasetya, Billy Massie, Mira Yuniarti, Nicolaski Lumbuun, Raymond Pranata, Cindy Meidy, Eka Julianta Wahjoepramono, Irawan Yusuf
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:International Journal of Infectious Diseases
Subjects:
Angiotensin
Candesartan
Coronavirus
SARS-CoV-2
Severity
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221004203

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221004203

Similar Items